These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3001201

  • 21. [Serum tissue polypeptide antigen (TPA) in patients with urogenital cancer].
    Matsushima M, Kuwabara T, Miyamae K, Hachiya A, Kawahara M, Fukasawa K, Yagishita T, Tajima M, Sawamura Y, Shirai M.
    Hinyokika Kiyo; 1984 Jul; 30(7):869-75. PubMed ID: 6507205
    [Abstract] [Full Text] [Related]

  • 22. [Tissue polypeptide antigen (TPA) in urological malignancies. I. S-TPA in bladder cancer patients].
    Akiyama T, Tsujihashi H, Boku E, Nagai N, Matsuura T, Iguchi M, Yachiku S, Kurita T.
    Hinyokika Kiyo; 1983 Dec; 29(12):1635-40. PubMed ID: 6677110
    [Abstract] [Full Text] [Related]

  • 23. Serum levels of T.P.A. (tissue polypeptide antigen) in gynecological malignancies.
    Restaino A, Fanizza G, Battarino O.
    Eur J Gynaecol Oncol; 1986 Dec; 7(3):183-5. PubMed ID: 3780759
    [Abstract] [Full Text] [Related]

  • 24. [Detection of CA-125 antigen (non-mucinous ovarian cancer antigen)-- in serum of patients with gynecological malignancies].
    Sakamoto S, Kawana H, Shimizu K, Ishihara T, Ueda K, Usman SM, Uchida S, Kawagoe K, Kihara K, Kubo H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1261-2. PubMed ID: 6595322
    [No Abstract] [Full Text] [Related]

  • 25. [Measurement of serum tissue polypeptide antigen (TPA) in patients with malignant tumor using prolifigen TPA-M "Daiichi" kit].
    Sakahara H, Endo K, Torizuka K, Itoh K, Ohuchi N, Inaba N, Miyaji Y, Takayama M, Ishii K, Takagi H, Konishi J, Fukuoka M, Fukuchi M, Ohkawa J, Kagawa S, Kondo S, Shirouzu K, Iguchi H.
    Gan To Kagaku Ryoho; 1996 May; 23(6):733-43. PubMed ID: 8645025
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [The clinical value of tissue polypeptide antigen in ovarian carcinoma].
    Wu L, Sun J, Wang X.
    Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):92-4. PubMed ID: 10682428
    [Abstract] [Full Text] [Related]

  • 30. [Serum CA 125 and TPA determination in malignant neoplasms of the uterus].
    Gadducci A, Facchini V, Bartolini T, Fioretti P.
    Ann Ostet Ginecol Med Perinat; 1988 Feb; 109(3):151-5. PubMed ID: 3207319
    [No Abstract] [Full Text] [Related]

  • 31. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM, Gaarenstroom KN, Korse CM, Van Bunningen BN, Kenemans P.
    Anticancer Res; 1997 Feb; 17(3C):2329-34. PubMed ID: 9245246
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
    Yabushita H, Sawaguchi K, Hieda S, Ogawa A, Tomatsu A, Noguchi M, Ishihara M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
    [Abstract] [Full Text] [Related]

  • 36. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor.
    Tamakoshi K, Kikkawa F, Shibata K, Tomoda K, Obata NH, Wakahara F, Tokuhashi Y, Ishikawa H, Kawai M, Tomoda Y.
    Gynecol Oncol; 1996 Jul; 62(1):67-72. PubMed ID: 8690294
    [Abstract] [Full Text] [Related]

  • 37. [Value of CA 125 in comparison to conventional tumor markers in ovarian cancer].
    Paulick R, Kaesemann H, Caffier H.
    Geburtshilfe Frauenheilkd; 1986 Aug; 46(8):509-14. PubMed ID: 2875919
    [Abstract] [Full Text] [Related]

  • 38. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V, Björklund B.
    Cancer Detect Prev; 1983 Aug; 6(1-2):193-8. PubMed ID: 6883380
    [Abstract] [Full Text] [Related]

  • 39. [Clinical evaluation of tissue polypeptide antigen in patients with esophageal, stomach and colon cancer].
    Ogoshi K, Kondo Y, Akiba Y, Sugihara T, Ko S, Noto T, Makuuchi H, Tajima T, Mitomi T.
    Gan No Rinsho; 1984 Aug; 30(10):1299-302. PubMed ID: 6481966
    [Abstract] [Full Text] [Related]

  • 40. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN, Kenter GG, Bonfrer JM, Korse CM, Van de Vijver MJ, Fleuren GJ, Trimbos JB.
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.